4,888
Participants
Start Date
August 1, 2019
Primary Completion Date
August 1, 2023
Study Completion Date
August 1, 2023
Metformin
Newly Initiated and regular metformin dosage as prescribed by each patient's medical care provider
Sulfonylurea
Newly initiated and regular sulfonylurea dosage as prescribed by each patient's medical care provider
DPP-4 inhibitor
Newly initiated and regular DPP-4 inhibitor dosage as prescribed by each patient's medical care provider
SGLT2 inhibitor
Newly initiated and regular SGLT2 inhibitor dosage as prescribed by each patient's medical care provider
GLP1 receptor agonist
Newly initiated and regular GLP1 receptor agonist dosage as prescribed by each patient's medical care provider
University of North Carolina, Chapel Hill
Vanderbilt University Medical Center, Nashville
Patient-Centered Outcomes Research Institute
OTHER
Weill Medical College of Cornell University
OTHER